Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 26875638] PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context
AOD-9604 vs Alternatives Compared to GHRH analogs such as tesamorelin or CJC-1295, which act upstream by stimulating pituitary GH release and downstream IGF-1, AOD-9604 operates further down the pathway with a narrower receptor footprint
Pre-mixed at the optimal ratio by a compounding pharmacy
(Reference standard for endotoxin limits.) Sikiric P, Seiwerth S, Rucman R, et al
SLU-PP-332 Regulatory Status As of June 2026, SLU-PP-332 is not approved by the FDA, EMA, or any other major regulator for any human indication